Global Export of Heparin for Therapeutic Use Share by Country (US Dollars)

The global export of heparin in 2023 was dominated by China, accounting for the largest share and showing over 2% growth. France and Singapore followed, both experiencing declines, with the United States also seeing a dropped share by over 5%. Emerging players like Poland and Israel displayed significant increases of over 7%. In contrast, Canada and Switzerland faced pronounced decrements in their export values. Notably, nations like Slovakia and Armenia experienced remarkable growth rates of over 28% and 140% respectively, indicating strong emerging potential within these markets.

Future trends to watch include China's continued dominance in heparin exports. Additionally, emerging markets in Eastern Europe and Asia-Pacific, driven by technological advancements and increasing health sector capabilities, could shape the dynamic landscape, potentially boosting their global market shares. Monitoring these regions will be essential for strategic market positioning.